13F HOLDINGS REPORT
M28 Capital Management LP
Quarter ended Q1 2023 · Filed February 10, 2023 · Accession 0000902664-23-001466
Total Value
$104.9M
Positions
14
Other Managers
0
Confidential Omitted
No
Holdings (14)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 5,903,405 | $41.3M | 39.39% |
| 2 | ROCKET PHARMACEUTICALS INC | RCKTW | 722,080 | $14.1M | 13.47% |
| 3 | INVIVYD INC | IVVD | 9,248,250 | $13.9M | 13.22% |
| 4 | PROQR THRAPEUTICS N V | N71542109 | 1,910,600 | $7.1M | 6.74% |
| 5 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 143,900 | $5.8M | 5.56% |
| 6 | IONIS PHARMACEUTICALS INC | IONS | 126,300 | $4.8M | 4.55% |
| 7 | STOKE THERAPEUTICS INC | STOK | 482,890 | $4.5M | 4.25% |
| 8 | BRIDGEBIO PHARMA INC | BBIO | 419,000 | $3.2M | 3.04% |
| 9 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 109,900 | $2.9M | 2.72% |
| 10 | CURIS INC | CRIS | 4,482,142 | $2.5M | 2.35% |
| 11 | SILENCE THERAPEUTICS PLC | SLNCF | 145,900 | $2.2M | 2.12% |
| 12 | ATARA BIOTHERAPEUTICS INC | ATRA | 439,300 | $1.4M | 1.37% |
| 13 | TG THERAPEUTICS INC | TGTX | 104,400 | $1.2M | 1.18% |
| 14 | NEXIMMUNE INC | 65344D109 | 133,442 | $32,440 | 0.03% |